Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1987 Jul;206(1):40–47. doi: 10.1097/00000658-198707000-00006

Regional therapy in the management of intrahepatic recurrence after surgery for hepatoma.

Y Sasaki, S Imaoka, M Fujita, Y Miyoshi, H Ohigashi, O Ishikawa, H Furukawa, H Koyama, T Iwanaga, H Kasugai, et al.
PMCID: PMC1492936  PMID: 3038040

Abstract

The significance of regional therapy against the intrahepatic recurrence for hepatocellular carcinoma (HCC) was evaluated. During the past 6 years, 101 patients who had radical operations for HCC (liver cirrhosis, 75%; chronic hepatitis, 22%) were followed. Forty-seven patients (47%) had recurrences; the liver was the site of first recurrence in 43 patients and distant site recurrence in four patients. In the patients where the liver was the recurrent site, 33 patients (77%) received regional therapies for an aggregate total of 60 times. Transcatheter arterial chemoembolization was chosen as the first preferred therapy against recurrence in the liver in 30 of 33 patients (91%). Postrecurrence survival of the patients treated with regional therapy was significantly better than disease-free survival (p less than 0.001). Disease-free survival after surgery, postrecurrence survival, and postsurgery survival were compared in the patients treated with regional therapy and untreated patients. Fifty per cent survival after recurrence of the treated patients was 27 months, and that of the untreated patients was 3 months. Postrecurrence survival (p less than 0.001) and postsurgery survival (p less than 0.01) of the treated patients were significantly better than those of the untreated patients. To obtain successful long-term survival after surgery for the cirrhotic patients with HCC, it is necessary to repeat active regional therapies against the recurrent liver.

Full text

PDF
40

Images in this article

46Figs. 9A and B.
on p.46

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adson M. A., Weiland L. H. Resection of primary solid hepatic tumors. Am J Surg. 1981 Jan;141(1):18–21. doi: 10.1016/0002-9610(81)90005-2. [DOI] [PubMed] [Google Scholar]
  2. Fortner J. G., Kim D. K., Maclean B. J., Barrett M. K., Iwatsuki S., Turnbull A. D., Howland W. S., Beattie E. J., Jr Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg. 1978 Sep;188(3):363–371. doi: 10.1097/00000658-197809000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Kanematsu T., Takenaka K., Matsumata T., Furuta T., Sugimachi K., Inokuchi K. Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg. 1984 Jan;199(1):51–56. doi: 10.1097/00000658-198401000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lee C. S., Sung J. L., Hwang L. Y., Sheu J. C., Chen D. S., Lin T. Y., Beasley R. P. Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma. Surgery. 1986 Apr;99(4):481–490. [PubMed] [Google Scholar]
  5. Makuuchi M., Hasegawa H., Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet. 1985 Oct;161(4):346–350. [PubMed] [Google Scholar]
  6. Nagasue N., Kobayashi M., Iwaki A., Yukaya H., Kanashima R., Inokughi K. Effect of 5-fluorouracil on liver regeneration and metabolism after partial hepatectomy in the rat. Cancer. 1978 Feb;41(2):435–443. doi: 10.1002/1097-0142(197802)41:2<435::aid-cncr2820410209>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  7. Nagasue N., Yukaya H., Ogawa Y., Sasaki Y., Chang Y. C., Niimi K. Clinical experience with 118 hepatic resections for hepatocellular carcinoma. Surgery. 1986 Jun;99(6):694–701. [PubMed] [Google Scholar]
  8. Nagasue N., Yukaya H., Ogawa Y., Sasaki Y., Chang Y. C., Niimi K. Second hepatic resection for recurrent hepatocellular carcinoma. Br J Surg. 1986 Jun;73(6):434–438. doi: 10.1002/bjs.1800730606. [DOI] [PubMed] [Google Scholar]
  9. Ohishi H., Uchida H., Yoshimura H., Ohue S., Ueda J., Katsuragi M., Matsuo N., Hosogi Y. Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology. 1985 Jan;154(1):25–29. doi: 10.1148/radiology.154.1.2981114. [DOI] [PubMed] [Google Scholar]
  10. Okamoto E., Kyo A., Yamanaka N., Tanaka N., Kuwata K. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery. 1984 May;95(5):586–592. [PubMed] [Google Scholar]
  11. Okamoto E., Tanaka N., Yamanaka N., Toyosaka A. Results of surgical treatments of primary hepatocellular carcinoma: some aspects to improve long-term survival. World J Surg. 1984 Jun;8(3):360–366. doi: 10.1007/BF01655077. [DOI] [PubMed] [Google Scholar]
  12. Ozawa K., Yamaoka Y., Kitamura O., Nambu H., Kamiyama Y. Clinical application of cytochrome a(plus a3) assay of mitochondria from liver specimens: an aid in determining metabolic tolerance of liver remnant for hepatic resection. Ann Surg. 1974 Dec;180(6):868–876. doi: 10.1097/00000658-197412000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sasaki Y., Imaoka S., Hasegawa Y., Nakano S., Ishikawa O., Ohigashi H., Taniguchi K., Koyama H., Iwanaga T., Terasawa T. Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer. Cancer. 1985 Jan 15;55(2):311–316. doi: 10.1002/1097-0142(19850115)55:2<311::aid-cncr2820550202>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  14. Sasaki Y., Imaoka S., Nakamori S., Ishikawa O., Ohigashi H., Koyama H., Taniguchi K., Iwanaga T., Fujita M., Kawamoto S. [Effect of intra-arterial injection of a lipiodol-adriamycin suspension combined with arterial embolization on hepatocellular carcinoma]. Nihon Gan Chiryo Gakkai Shi. 1985 Aug 20;20(7):1357–1365. [PubMed] [Google Scholar]
  15. Sheu J. C., Lee C. S., Sung J. L., Chen D. S., Yang P. M., Lin T. Y. Intraoperative hepatic ultrasonography--an indispensable procedure in resection of small hepatocellular carcinomas. Surgery. 1985 Jan;97(1):97–103. [PubMed] [Google Scholar]
  16. Tanaka Y., Nagasue N., Kanashima R., Inokuchi K., Shirota A. Effect of doxorubicin on liver regeneration and host survival after two-thirds hepatectomy in rats. Cancer. 1982 Jan 1;49(1):19–24. doi: 10.1002/1097-0142(19820101)49:1<19::aid-cncr2820490105>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  17. Tsuzuki T., Ogata Y., Iida S., Shimazu M. Hepatic resection in 125 patients. Arch Surg. 1984 Sep;119(9):1025–1032. doi: 10.1001/archsurg.1984.01390210029008. [DOI] [PubMed] [Google Scholar]
  18. Yamada R., Sato M., Kawabata M., Nakatsuka H., Nakamura K., Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology. 1983 Aug;148(2):397–401. doi: 10.1148/radiology.148.2.6306721. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES